Shopping Cart 0
Cart Subtotal

MediPoint: Vertebroplasty Devices-Europe Analysis and Market Forecasts

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 5000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 10000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 15000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies


MediPoint: Vertebroplasty Devices-Europe Analysis and Market Forecasts


Vertebral compression fractures (VCFs) are often characterized by pain and deformity due to the fracture and collapse of one or more vertebral bodies in the spinal column. Primarily caused by osteoporosis and osteopenia-conditions characterized by loss of bone mass and low bone mineral density-the number of diagnosed VCF cases is increasing globally as the population ages and incidences of the aforementioned conditions grow. In general, these fractures are initially treated non-surgically with pharmacological therapies, bracing, and rest. In the event that non-surgical treatment fails to relieve pain, surgical treatment can be implemented.

Vertebroplasty and kyphoplasty are minimally invasive, fluoroscopy-guided surgical techniques that utilize acrylic cement injected into the damaged vertebral body to stabilize the fracture. Kyphoplasty is an advanced version of the conventional vertebroplasty procedure, and novel approaches such as this are causing slowed growth or decline of vertebroplasty in many mature markets. However, the exceedingly cheaper vertebroplasty procedure continues to be adopted in emerging countries where cost is a significant factor.

This report focuses on the market outlook for vertebroplasty products in Europe (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey, and UK). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.

Key Questions Answered

What is the current and future vertebroplasty market outlook in the developed and emerging markets? What trends are affecting the European market?

Which are the key, high growth markets that vertebroplasty manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?

What are the unmet needs with the current generation of vertebroplasty products? How will emerging technologies fulfill these unmet needs?

What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for vertebroplasty?

What are the challenges and complications that have hindered widespread adoption?

With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the vertebroplasty market?


Overview of recent key industry events and analysis of their market impact.

Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.

Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.

Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.

Analysis of the current and future market competition in the European vertebroplasty market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to

Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

Develop business strategies by understanding the trends shaping and driving the vertebroplasty market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the vertebroplasty market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in country-specific vertebroplasty markets from 2014-2023.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.


Table Of Content


Table of Contents

1 About the Authors 2

1.1 Analysts 2

1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices 2

1.1.2 Linda Tian, Managing Analyst, Medical Devices 2

1.2 Global Head of Medical Devices 2

2 Table of Contents 3

2.1 List of Tables 5

2.2 List of Figures 5

3 Executive Summary 6

3.1 Overview 6

3.2 Market Dynamics 7

3.3 Key Players in the Vertebroplasty Market 8

3.4 Vertebroplasty Market Future Outlook 8

4 Introduction 9

4.1 Catalyst 9

4.2 Related Reports 9

4.3 Upcoming Related Reports 10

5 Market Outlook 11

5.1 Procedure Trends 11

5.2 Pricing Trends 12

5.3 Revenue Trends 14

5.4 Company Share Analysis 15

6 Market Insights 16

6.1 Europe 16

6.1.1 Denmark, Finland, Norway, and Sweden 16

6.1.2 Belgium, France, and Netherlands 16

6.1.3 Germany and Switzerland 17

6.1.4 UK and Ireland 17

6.1.5 Italy, Portugal, and Spain 17

6.1.6 Austria, Czech Republic, Hungary, and Poland 17

6.1.7 Greece, Russia, and Turkey 18

7 Competitive Assessment 19

7.1 Overview 19

7.2 DePuy Synthes (Johnson & Johnson) 19

7.2.1 Overview 19

7.2.2 Portfolio Assessment 19

7.2.3 Competitive Positioning 20

7.3 Globus Medical 20

7.3.1 Overview 20

7.3.2 Portfolio Assessment 21

7.3.3 News and Deals Analysis 21

7.3.4 Competitive Positioning 21

7.4 Medtronic 21

7.4.1 Overview 21

7.4.2 Portfolio Assessment 22

7.4.3 Competitive Positioning 23

7.5 Stryker 23

7.5.1 Overview 23

7.5.2 Portfolio Assessment 24

7.5.3 News and Deals Analysis 24

7.5.4 Competitive Positioning 24

7.6 Other Players 25

8 Appendix 26

8.1 Bibliography 26

8.2 Abbreviations 26

8.3 Methodology 27

8.3.1 Overview 27

8.3.2 Coverage 27

8.3.3 Secondary Research 27

8.3.4 Forecasting Methodology 28

8.3.5 Primary Research Summary 29

8.4 About MediPoint 30

8.5 About GlobalData 30

8.6 Contact Us 30

8.7 Disclaimer 31

List Of Figure

List of Figures

Figure 1: Vertebroplasty Sales for Europe, by Country, 2016 and 2023 7

List Of Table

List of Tables

Table 1: Key Metrics in the Europe Vertebroplasty Market 6

Table 2: Europe Vertebroplasty Volume Forecast, 2014-2023 11

Table 3: Europe Vertebroplasty Average Selling Price Forecast ($), 2014-2023 12

Table 4: Europe Vertebroplasty Market Revenue Forecast ($M), 2014-2023 14

Table 5: Europe VCF Repair Company Share Analysis, 2016 15

Table 6: DePuy Synthes-Key Marketed Products Assessment 19

Table 7: Globus Medical-Key Marketed Products Assessment 21

Table 8: Medtronic-Key Marketed Products Assessment 22

Table 9: Stryker-Key Marketed Products Assessment 24

Table 10: Summary of Other Players in the Vertebroplasty Market, 2017 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to

Products and Companies


DePuy Synthes (Johnson & Johnson)

Globus Medical